Study Group: Physicians who Implant the COSTAR Drug Eluting Stent
Council Members in this Study Group: 31
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Charles O'Shaughnessy
Director of Interventional Cardiology
NORTH OHIO HEART CENTER, INC
Charles O'Shaughnessy, MD, is the Director of Interventional Cardiology at North Ohio Heart Center, Ohio. Dr. O'Shaughnessy's clinical interests are in interventional cardiology including balloon angioplasty, laser directional atherectomy, stent placement,...
Giuseppe Biondi-ZoccaiAssistant Professor of Cardiology
University of TurinGiuseppe Biondi-Zoccai, MD, is an Assistant Professor of Cardiology and an Attending Physician in Interventional Cardiology at the University of Turin, Italy, since October 2006. Dr. Biondi-Zoccai has expertise in interventional cardiology, peripheral...
- Antonio Colombo
Director of the Cardiac Catheterization Laboratory
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABORAntonio Colombo, MD, is Director of the Cardiac Catheterization Laboratory at Columbus Hospital and San Raffaele Hospital in Milan, Italy. He is also a Visiting Professor of Medicine at Columbia University Hospital and Professor of Clinical Medicine at...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
December 5, 2008
Generic Heart Drugs as Good as Brand-Name Counterparts | www.washingtonpost.com
Generic drugs are cheaper equivalent of brand-name (aka proprietary) drugs which become available after a specific drug patent expires. There is ongoing debate whether generic drugs are as safe and as effective as their brand-name counterparts. Recent evidence from a comprehensive review published in the authoritative Journal of the American Medical Association suggests that generic drugs for heart disease are as safe and as effective as the corresponding proprietary drugs. Thus, given their lower cost, generic drugs may progressively reduce the market share of brand-name drugs, especially whenever a proprietary drug is very expensive or its market position depends only on monopoly rather than effective branding and marketing.
-
May 30, 2008
Metabolic Syndrome Not Useful in Predicting Cardiovascular Risk | www.medpagetoday.com
Metabolic syndrome is a cluster of individual characteristics that has been preliminarily associated with adverse events such as heart attack and stroke If proved an independent cause of cardiovascular disease, metabolic. syndrome could become another feasible target of pharmacologic primary prevention, eg of rimonabant, a novel drug from Sanofi-Aventis that is also under investigation for the treatment/prevention of obesity. However, recent data published in a leading journal, the Lancet, cast a shadow of doubt on independent causal role of the metabolic syndrome, suggesting that its unfavorable impact on patient outlook is largely explained by other risk factors such as increased blood pressure, increased blood lipids, and inflammation.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Office Based Private Practice or Clinic
- Government/Military Hospital or Clinic
- Medical Device Manufacturer
- Research Foundation
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Physician - Other Administration
- Chief Medical Officer
- President